Logo

methylation

Banner Year for Blood-Based Cancer Screening in 2021, but Reimbursement and Utility Hurdles Loom
Premium

New companies claimed stakes during the year, established firms solidified their plans and data, and Grail launched the first genomic multi-cancer early detection test.

Nucleix Raises Additional $22M

The Israeli molecular diagnostics firm is developing liquid biopsy tests for early-stage and recurring cancer detection based on methylation patterns.

Long Cell-Free DNA Molecules Could Provide New Target for Noninvasive Prenatal Testing
Premium

A new study has explored patterns in these molecules in pregnant women, showing potential for detection of fetal monogenic diseases and pregnancy complications.

Saga Diagnostics, AstraZeneca Ink Digital PCR Assay Development Deal

Lund, Sweden-based Saga will develop assays using its SagaSafe digital PCR technology for undisclosed methylated targets in both blood and tissue. 

Pancreatic Cancer Data Preview Freenome's Plans for Expanded Cancer Detection Assay
Premium

The company shared new results from a pilot study training its platform to detect pancreatic cancers, showing high sensitivity in stage II to stage III tumors.

Sep 28, 2021

Identical Twins Carry Lifelong Epigenetic Signature Reflecting Early Genomic Events

Sep 23, 2021

Zymo Research Gets CE Mark for DNA Methylation Kit

Aug 16, 2021

Advanced Gastric Cancer Multiomic Analysis Reveals New Potential Therapeutic Targets

Aug 5, 2021

Lung Cancer Features, Treatment Clues Emerge From 'Omic Analysis of Difficult-to-Treat Subtype

Jul 1, 2021

Canadian Liquid Biopsy Startup Adela to Pursue Cancer Early Detection Tests
Premium

Jun 25, 2021

Seasonal Influenza Vaccination Leads to Immune Cell Epigenomic Changes

Jun 23, 2021

Liquid Biopsy Startup Adela Launches With $60M Series A Financing Round

Jun 15, 2021

South Korean Firm EDGC to Expand Reach Into Liquid Biopsy Space With Cell-Free DNA Platform
Premium

Jun 11, 2021

Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership

Jun 10, 2021

Alzheimer's Disease Meta-Analysis Identifies Novel Differentially Methylated Loci

Jun 3, 2021

Nucleix, MD Anderson Partner on Methylation-Based Lung Cancer Dx Tests

May 26, 2021

Acute Lymphoblastic Leukemia Study Explores Role of DNA Methylation in Outcomes, Treatment

May 26, 2021

Burning Rock Embarks on Large-Scale Study for 22-Cancer Screening Assay
Premium

May 19, 2021

BGI Genomics Nabs CE Mark for Colorectal Cancer Screening Test

May 18, 2021

TruDiagnostic Receives CLIA Certification for Kentucky Laboratory

Apr 15, 2021

Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches
Premium

Apr 1, 2021

Guardant Health Receives New York State Approval for Guardant Reveal MRD Test

Mar 11, 2021

Burning Rock Q4 Revenues Rise 50 Percent

Mar 1, 2021

Host DNA Methylation Signatures May Predict Likelihood of Persistent, Resolving MRSA Infections

Feb 26, 2021

Guardant Health Begins First Foray Into Early-Stage Cancer With Commercial MRD Test Launch
Premium

Breaking News
The Scan

Omicron's Sewage Path

The New York Times writes that testing sewage is helping public health officials track Omicron.

IBM Sells Part of Watson Health

The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm.

Identifying the Right Whales

The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought.

Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer

In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.